Waning of Anti-SARS-CoV-2 Spike Antibody Levels 100 to 200 Days after the Second Dose of the BNT162b2 Vaccine

Anti-SARS-CoV-2 antibodies of 444 vaccinated hospital employees in Japan were measured 94–109 days and 199–212 days after receiving the second BNT162b2 vaccine dose to evaluate the intensity and duration of antibody response in our own cohort. Among uninfected participants, anti-S antibody levels we...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsunaga, Hidenori, Takeuchi, Hidefumi, Oba, Yuichiro, Fujimi, Satoshi, Honda, Tomoyuki, Tomonaga, Keizo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879303/
https://www.ncbi.nlm.nih.gov/pubmed/35214636
http://dx.doi.org/10.3390/vaccines10020177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879303/
https://www.ncbi.nlm.nih.gov/pubmed/35214636
http://dx.doi.org/10.3390/vaccines10020177

Ejemplares similares